Carto 3
Device Cardiology
PDI 10846835009439
General payments
$22,351,749
Research payments
$384,277
Through program year 2025, $22,351,749 in general payments and $384,277 in research payments were reported against Carto 3 (Cardiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6,840,341 | 30,052 |
| 2025 | Research | $107,308 | 7 |
| 2024 | General | $5,531,652 | 27,806 |
| 2024 | Research | $102,000 | 7 |
| 2023 | General | $4,176,608 | 20,917 |
| 2023 | Research | $102,650 | 4 |
| 2022 | General | $3,461,191 | 16,008 |
| 2022 | Research | $8,415 | 2 |
| 2021 | General | $2,341,958 | 10,964 |
| 2021 | Research | $63,904 | 6 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 102 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
105,747 general · 26 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.